Conditions: Healthy Volunteers
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 43
Healthy volunteers: yes

Brief summary:
The main purpose of this study is to evaluate the safety and tolerability of the study drug known as LY3084077 in healthy participants. The study will also investigate how much of the study drug gets into the blood stream and how long it takes the body to get rid of it. Information about any side effects that may occur will also be collected. The study is expected to last approximately 8 weeks for each participant.

Detailed description:

Arms:
arm 1: Single dose of placebo matching LY3084077 administered subcutaneously (SC). arm 2: Single escalating doses (1 mg up to 300 mg) of LY3084077 administered SC.

Interventions: intervention 1: Placebo intervention 2: LY3084077
Intervention descriptions: intervention 1: Given as a SC injection. intervention 2: Given as a SC injection.

Protocol document: